Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Penumbra's Pre-Tax Income for the
three
months ended in Dec. 2024 was $44 Mil. Penumbra's Revenue for the
three
months ended in Dec. 2024 was $316 Mil. Therefore, Penumbra's pretax margin for the quarter that ended in Dec. 2024 was 14.05%.
The historical rank and industry rank for Penumbra's Pretax Margin % or its related term are showing as below:
PEN'
s Pretax Margin % Range Over the Past 10 Years
Min: -6.78 Med: 0.6 Max: 9.16
Current: 1.75
PEN's Pretax Margin % is ranked better than 51.89% of 819
companies
in the Medical Devices & Instruments industry
Industry Median: 0.66
vs PEN: 1.75
Penumbra Pretax Margin % Historical Data
The historical data trend for Penumbra's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Penumbra's Pretax Margin %
For the Medical Devices subindustry, Penumbra's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Penumbra's Pretax Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Penumbra's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Penumbra (NYSE:PEN) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Penumbra Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Penumbra's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PEN has been successfully added to your 